Patents

  1. Krasavin, M. Yu.; Garabadzhiu, A. V.; Zhukov, A. S.; Khairutdinov, V. R. Pharmaceutical composition for the psoriasis treatment. Russian Federation Patent (2021) RU 2742879, 13 pp.
  2. Krasavin, M. Yu.; Trifonov, R. E.; Tolstyakov, V. V.; Darin, D. V.; Vinogradova, T. I.; Manicheva, O. A.; Dogonadze, M. Z.; Zabolotnykh, N. V.; Vitovskaya, M. L.; Yablonskii, P. K. 5-Methyl-7-(3-nitro-[1,2,4]triazol-1-yl)-[1,2,4]triazolo[1,5-a]pyrimidine, having anti-tuberculosis activity against the agent with multiple drug resistance, and a method for production thereof. Russian Federation Patent (2019) RU 2705591, 16 pp.
  3. Krasavin, M. Yu.; Darin, D. V.; Kantin, G. P. Method of producing α-diazocarbonyl compounds in aqueous medium. Russian Federation Patent (2019) RU 2686489, 44 pp.
  4. Dorogov, M. V.; Krasavin, M. Yu. Aromatic derivatives of sulfanilamides carbonic anhydrase II (CA II) inhibitors, methods for production and use thereof. Russian Federation Patent (2017) RU 2607630, 43 pp.
  5. Papeo, G. M. E.; Borghi, D.; Caruso, M.; Posteri, H.; Krasavin, M. Y. 3-Oxo-2, 3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors. US Patent 9,073,893 (July 15, 2015).
  6. Dorogov, M. V.; Krasavin, M. Yu. 2-Aryl-Substituted N-Arylimidazolines, Selective Cyclooxygenase-2 Inhibitors, Methods for Production and Use THereof. Russian Federation Patent (2015) RU2565667, 41 pp.
  7. Papeo, G. M. E.; Orsini, P.; Scolaro, A.; Krasavin, M. Preparation of carboxamido-isoindolinone derivatives as selective PARP-1 inhibitors. (Nerviano Medical Sciences) PCT Int. Appl. (2014), 60 pp. WO20142014064149A1.
  8. Gakh, A. A.; Krasavin, M.; Karapetian, R.; Rufanov, K. A.; Konstantinov, I.; Godovykh, E.; Soldatkina, O.; Sosnov, A. V. Anti-cancer agents based on n-acyl-2, 3-dihydro-1H-pyrrolo[2,3-b] quinoline derivatives and a method of making. (US Department of Energy). US Patent 8,420,815, 6 pp. (2013).
  9. Papeo, G. M. E.; Borghi, D.; Caruso, M.; Posteri, H.; Krasavin, M. Y. 3-Oxo-2,3-dihydro-1H-indazole-4-carboxamide derivatives as PARP-1 inhibitors. (Nerviano Medical Sciences) PCT Int. Appl. (2013), 43 pp. WO2013014038A1.
  10. Gakh, A. A.; Krasavin, M.; Karapetian, R.; Rufanov, K. A.; Konstantinov, I.; Godovykh, E.; Soldatkina, O.; Sosnov, A. V. Anti-cancer agents based on 4-(hetero)aryl-1,2,5-oxadiazol-3-yl amino derivative and a method of making. (US Department of Energy). US Patent 8,362,047, 6 pp. (2013).
  11. Papeo, G. M. E.; Anatolievna Busel, A.; Khvat, A.; Krasavin, M. Y.; Forte, B.; Zuccotto, F. 3-Oxo-2,3-dihydro-1H-isoindole-4-carboxamides as PARP Inhibitors. (Nerviano Medical Sciences). PCT Int. Appl. (2011), 69 pp., WO 2011006794.
  12. Papeo, G. M. E.; Anatolievna Busel, A.; Casale, E.; Khvat, A.; Krasavin, M. Y.; Orsini, P.; Posteri, H.; Scolaro, A. 3-0xo-2,3-dihydro-1H-isoindole-4-carboxamides with selective PARP-1 inhibitions. (Nerviano Medical Sciences). PCT Int. Appl. (2011), 73 pp., WO 2011006803.
  13. Posner, G. H., Parker, M. H.; Krasavin, M.; Shapiro, T. A. Synthesis and Activity of Water-Soluble Trioxanes as Potent and Safe Antimalarial Agents. (Johns Hopkins University). PCT International Application (2000), 82 pp., WO2000059501.
  14. Posner, G. H., Parker, M. H.; Krasavin, M.; Shapiro, T. A. Water-Soluble Trioxanes as Potent and Safe Antimalarial Agents. (Johns Hopkins University). U. S. Patent 6,136,847 (2000).
▲ Back to Top